HPS Pharmacies wish to advise that Pfizer is anticipating a supply interruption for Dostinex® tablets as follows:
Dostinex® Tablets
Cabergoline 0.5mg
ARTG 52158
This supply interruption affects pack sizes of 8 tablets; the bottle presentation containing two tablets is not expected to be affected. Pfizer anticipates supply issues to begin in May and resolve by end-June 2023.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Pfizer on 1800 675 229, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates